English press releases

WisdomTree Reports Monthly Metrics for December 2022

2022 net inflows over $12 billion Nine consecutive quarters of net inflows Record global AUM approaching $82 billion NEW YORK–(BUSINESS WIRE)– WisdomTree, Inc. (NYSE: WT),...

Samsung Electronics Unveils High-Performance PC SSD that Raises Everyday Computing and Gaming to a New Level

Built with a market-leading 5nm controller and seventh-generation V-NAND, the PM9C1a will enable a new level of everyday PC efficiency, while also handling demanding computing...

United Arab Emirates Announces Diverse Leadership Team for UNFCCC Climate Change Conference (COP28) Focused on Raising Global Climate Ambition

ABU DHABI, United Arab Emirates–(BUSINESS WIRE)– Under the directive of the President of the UAE, His Highness Sheikh Mohamed bin Zayed Al Nahyan, the Deputy...

Logitech Announces Preliminary Third Quarter Fiscal Year 2023 Results

Company Reduces Fiscal Year 2023 Outlook LAUSANNE, Switzerland & NEWARK, Calif.–(BUSINESS WIRE)– SIX Swiss Exchange Ad hoc announcement pursuant to Art. 53 LR — Logitech...

IFF Recognized for Achieving Sustainability Leadership Throughout Transformational Year

Named to DJSI for third time, recognized with CDP “A” score on climate change for eighth time NEW YORK–(BUSINESS WIRE)– IFF (NYSE:IFF) today announced it...

SES Secures €300M Financing from European Investment Bank

EIB loan will help fund SES’s three fully digital satellites serving Western Europe, Africa and the Middle East Satellites to deliver high-speed broadband and reliable...

IFF’s Philippe Horvath Inducted into The National Inventors Hall of Fame

Molecular biologist honored for contributions to science, enhancing global food supply and laying the foundation for gene editing NEW YORK–(BUSINESS WIRE)– Philippe Horvath—renowned molecular biologist...

Boehringer Ingelheim and 3T Biosciences Join Forces to Develop Next-Generation Cancer Immunotherapies

INGELHEIM, Germany & SAN FRANCISCO–(BUSINESS WIRE)– Boehringer Ingelheim and 3T Biosciences, today announced they have entered into a strategic collaboration and licensing agreement to discover...

Arrowhead and Takeda Announce Topline Results from SEQUOIA Phase 2 Study of Fazirsiran in Patients with Alpha-1 Antitrypsin Deficiency-Associated Liver Disease

− Fibrosis regression observed in 50% of patients receiving fazirsiran − Median reductions of 94% of Z-AAT accumulation in the liver and mean reduction of...

Ardoq Named to Denmark’s SKI Procurement Service for the Public Sector

Inclusion Streamlines Process for Public Organizations to Adopt Ardoq’s Enterprise Architecture Tool OSLO, Norway–(BUSINESS WIRE)– Ardoq, a SaaS company reinventing Enterprise Architecture (EA) for today’s...

Alibaba Cloud Unveils Its First International Product Innovation Center and Partner Management Center

Leading cloud service provider manifests its commitment to global customers, starting from its international headquarters in Singapore The cloud leader also attains the highest tier...

Ipsen to Acquire Albireo Accelerating Growth in Rare Disease With Treatments for Several Pediatric Liver Diseases

Transaction focused on Bylvay® (odevixibat), the first-approved treatment in progressive familial intrahepatic cholestasis in U.S. and E.U., with potential in other rare diseases Acquisition aligned...

Alipay+ promotes QR code connectivity, paving ways for a cash-free, mobile friendly travel experience in Chinese mainland for Asian consumers

– AlipayHK users are now able to pay for their metro rides in Shenzhen using their local app, as China begins to optimize regulations on...

Novocure Announces Pivotal LUNAR Study in Non-Small Cell Lung Cancer Met Primary Overall Survival Endpoint

The LUNAR study met its primary endpoint, demonstrating a statistically significant and clinically meaningful improvement in overall survival The full LUNAR data will be presented...

Takeda Announces Favorable Phase 3 Safety and Efficacy Results of TAK-755 as Compared to Standard of Care in Congenital Thrombotic Thrombocytopenic Purpura (cTTP)

Results are From First and Only Phase 3 Trial in cTTP, an Ultra-Rare Disease with Limited Treatment Options cTTP is Caused by a Deficiency in...